Eli Lilly & Co (US)

Eli Lilly & Co is a leading global pharmaceutical company with a particular strength in neuroscience and diabetes treatments. The group's current best-seller is schizophrenia drug Zyprexa, but Lilly is best-known for the anti-depressant Prozac, a miracle drug which revolutionised the treatment of depression during the 1980s and 1990s. The company suffered a slight decline in performance after the expiry of Prozac's patent, until the launch of a series of new products in 2003 and 2004. Advertising Age estimated global measured advertising expenditure of $357m in 2007, making Lilly the world's #94 advertiser. Click here to access the Adbrands profile (subscribers only); or subscribe to Adbrands.net here. Adbrands Company Profiles provide a detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including details of which advertising agency handles which accounts in which countries for major markets.

Advertising: Which agencies handle advertising for Eli Lilly? The searchable account assignments database is available to full subscribers to Adbrands.net premium services. Click here for subscription information

Competitors: see Pharmaceutical Sector index for other companies

Subscribers may access the following website links here:

Eli Lilly & Co website

Prozac	Humulin
Zyprexa	Humalog
Gemzar	Actos
Evista	Xigris
Strattera	Symbyax
Alimta	Cialis
Elanco	Cymbalta

Eli Lilly worldwide

Click HERE to subscribe to Adbrands.net and access the profile and website links